Herein, we report on the 5-step synthesis of new 3-[4-(arylalkoxy)phenylethyl]-2-thioxo-1,3-thiazolidin-4-ones without 5-arylidene fragments starting from tyramine The construction involved protection with Boc2O, regioselective O-alkylation, deprotection with 6 M HCl, neutralization, and finally reaction of bis(carboxymethyl)trithiocarbonate under microwave irradiation. The intermediates and the N-substituted rhodanine have been also evaluated for their in vitro inhibition of cell proliferation (Huh7, Caco 2, MDA-MB231, HCT 116, PC3, NCI-H727, HaCat). Two compounds have shown a selective potent activity against HCT116 cell line.
Similar content being viewed by others
References
Singh, S. P.; Parmar, S. S.; Raman, K.; Stenberg, V. I. Chem. Rev. 1981, 81, 175.
Tomašić, T.; Mašič, L. P. Expert Opin. Drug Discovery 2012, 7, 549.
Ray, J.; Panja, N.; Nandi, P. K.; Martin, J. J.; Jones, W. E. J. Mol. Struct. 2008, 874, 121.
Hotta, N.; Akanuma, Y.; Kawamori, R.; Matsuoka, K.; Oka, Y.; Shichiri, M.; Toyota, T.; Nakashima, M.; Yoshimura, I.; Sakamoto, N.; Shigeta, Y. Diabetes Care 2006, 29, 1538.
Ortiz, A.; Sansinenea, E. Curr. Org. Chem. 2011, 15, 108.
Song, H.; Lee, Y. S.; Roh, E. J.; Seo, J. H.; Oh, K.-S.; Lee, B. H.; Han, H.; Shin, K. J. Biorg. Med. Chem. Lett. 2012, 22, 5668.
Liu, J.-C.; Zheng, C.-J.; Wang, M.-X.; Li, Y.-R.; Ma, L.-X.; Hou, S.-P.; Piao, H.-R. Eur. J. Med. Chem. 2014, 74, 405.
Tomasic, T.; Masic, L. P. Curr. Med. Chem. 2009, 16, 1596.
Verma, A.; Saraf, S. K. Eur. J. Med. Chem. 2008, 43, 897.
Li, W.; Zhai, X.; Zhong, Z.; Li, G.; Pu, Y.; Gong, P. Arch. Pharm. 2011, 344, 349.
Brun, E.; Safer, A.; Carreaux, F.; Bourahla, K.; L'helgoua'ch, J. M.; Bazureau J.-P.; Villalgordo J. M. Molecules 2015, 20, 11617.
Coulibaly, W. K.; Paquin, L.; Bénie, A.; Békro, Y.-A.; Le Guével, R.; Ravache, M.; Corlu, A.; Bazureau, J.-P. Med. Chem. Res. 2015, 24, 1653.
Guiheneuf, S.; Paquin, L.; Carreaux, F.; Durieu, E.; Roisnel, T.; Meijer, L.; Bazureau, J.-P. Mol. Diversity 2014, 18, 375.
Radi, M.; Botta, L.; Casaluce, G.; Bernardini, M.; Botta, M. J. Comb. Chem. 2010, 12, 200.
Hart, M. E.; Suchland, K. L.; Miyakawa, M.; Bunzow, J. R.; Grandy, D. K.; Scanlan, T. S. J. Med. Chem. 2006, 49, 1101.
N'ta Ambeu, C.; Dago, C. D.; Coulibaly, W. K.; Békro, Y.-A.; Mamyrbékova-Békro, J. A.; Bazureau, J.-P. Curr. Microwave Chem. 2016, 3, 145.
Nakabayashi, H.; Taketa, K.; Miyano, K.; Yamane, T.; Sato, J. Cancer Res. 1982, 42, 3858.
Two of us (C.D.D. and C.N.A.) wish to thank the Benianh International Foundation, ElecBTP and the Ministère de l'Enseignement Supérieur et de la Recherche de la Côte d'Ivoire for their respective grants. Financial support of this program carried out under the French National Cancer Institute “Cancéropôle Grand Ouest” by contract “Ion Channel- Network CGO 2012”, is gratefully acknowledged.
The authors are grateful to the assistance of the staff of the CRMPO analytical chemistry core facility for HRMS analysis (CRMPO platform SFS ScanMAT, Université de Rennes 1, Bât. 11A, Campus de Beaulieu, Rennes, France).
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Khimiya Geterotsiklicheskikh Soedinenii, 2017, 53(3), 341–349
Rights and permissions
About this article
Cite this article
Dago, C.D., Ambeu, C.N., Coulibaly, W.K. et al. Investigation on the synthesis of new 3-[4-(arylalkoxy)phenylethyl]-2-thioxo-1,3-thiazolidin-4-ones and their biological evaluation against cancer cells. Chem Heterocycl Comp 53, 341–349 (2017). https://doi.org/10.1007/s10593-017-2056-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10593-017-2056-2